Report Detail
Global Dry Eye Drugs Market Growth 2019-2024
- RnM3282619 |
- 08 April, 2019 |
- Global |
- 138 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
The classification of Dry Eye Drugs includes Artificial Tears, Anti-inflammatory drugs and other, and the proportion of Artificial Tears in 2017 is about 89%.
North America is the largest consumption place, with a consumption market share nearly 40% in 2017. Following North America, Asia Pacific is the second largest consumption place with the consumption market share of 25%.
According to this study, over the next five years the Dry Eye Drugs market will register a 11.8% CAGR in terms of revenue, the global market size will reach US$ 9330 million by 2024, from US$ 5350 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Dry Eye Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Dry Eye Drugs market by product type, application, key manufacturers and key regions and countries.
This study considers the Dry Eye Drugs value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Artificial Tears
Anti-inflammatory Drugs
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Drug Stores
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Allergan
Novartis AG
Valeant Pharmaceuticals
Santen Pharma
Shire
Johnson & Johnson
United Laboratories
Senju Pharmaceutical
Jianfeng Group
Eusan GMBH
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Dry Eye Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Dry Eye Drugs market by identifying its various subsegments.
Focuses on the key global Dry Eye Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Dry Eye Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Dry Eye Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Dry Eye Drugs Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Dry Eye Drugs Consumption 2014-2024
- 2.1.2 Dry Eye Drugs Consumption CAGR by Region
- 2.2 Dry Eye Drugs Segment by Type
- 2.2.1 Artificial Tears
- 2.2.2 Anti-inflammatory Drugs
- 2.2.3 Other
- 2.3 Dry Eye Drugs Consumption by Type
- 2.3.1 Global Dry Eye Drugs Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Dry Eye Drugs Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Dry Eye Drugs Sale Price by Type (2014-2019)
- 2.4 Dry Eye Drugs Segment by Application
- 2.4.1 Hospital
- 2.4.2 Drug Stores
- 2.4.3 Online Pharmacies
- 2.5 Dry Eye Drugs Consumption by Application
- 2.5.1 Global Dry Eye Drugs Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Dry Eye Drugs Value and Market Share by Application (2014-2019)
- 2.5.3 Global Dry Eye Drugs Sale Price by Application (2014-2019)
3 Global Dry Eye Drugs by Players
- 3.1 Global Dry Eye Drugs Sales Market Share by Players
- 3.1.1 Global Dry Eye Drugs Sales by Players (2017-2019)
- 3.1.2 Global Dry Eye Drugs Sales Market Share by Players (2017-2019)
- 3.2 Global Dry Eye Drugs Revenue Market Share by Players
- 3.2.1 Global Dry Eye Drugs Revenue by Players (2017-2019)
- 3.2.2 Global Dry Eye Drugs Revenue Market Share by Players (2017-2019)
- 3.3 Global Dry Eye Drugs Sale Price by Players
- 3.4 Global Dry Eye Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Dry Eye Drugs Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Dry Eye Drugs Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Dry Eye Drugs by Regions
- 4.1 Dry Eye Drugs by Regions
- 4.1.1 Global Dry Eye Drugs Consumption by Regions
- 4.1.2 Global Dry Eye Drugs Value by Regions
- 4.2 Americas Dry Eye Drugs Consumption Growth
- 4.3 APAC Dry Eye Drugs Consumption Growth
- 4.4 Europe Dry Eye Drugs Consumption Growth
- 4.5 Middle East & Africa Dry Eye Drugs Consumption Growth
5 Americas
- 5.1 Americas Dry Eye Drugs Consumption by Countries
- 5.1.1 Americas Dry Eye Drugs Consumption by Countries (2014-2019)
- 5.1.2 Americas Dry Eye Drugs Value by Countries (2014-2019)
- 5.2 Americas Dry Eye Drugs Consumption by Type
- 5.3 Americas Dry Eye Drugs Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Dry Eye Drugs Consumption by Countries
- 6.1.1 APAC Dry Eye Drugs Consumption by Countries (2014-2019)
- 6.1.2 APAC Dry Eye Drugs Value by Countries (2014-2019)
- 6.2 APAC Dry Eye Drugs Consumption by Type
- 6.3 APAC Dry Eye Drugs Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Dry Eye Drugs by Countries
- 7.1.1 Europe Dry Eye Drugs Consumption by Countries (2014-2019)
- 7.1.2 Europe Dry Eye Drugs Value by Countries (2014-2019)
- 7.2 Europe Dry Eye Drugs Consumption by Type
- 7.3 Europe Dry Eye Drugs Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Dry Eye Drugs by Countries
- 8.1.1 Middle East & Africa Dry Eye Drugs Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Dry Eye Drugs Value by Countries (2014-2019)
- 8.2 Middle East & Africa Dry Eye Drugs Consumption by Type
- 8.3 Middle East & Africa Dry Eye Drugs Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Dry Eye Drugs Distributors
- 10.3 Dry Eye Drugs Customer
11 Global Dry Eye Drugs Market Forecast
- 11.1 Global Dry Eye Drugs Consumption Forecast (2019-2024)
- 11.2 Global Dry Eye Drugs Forecast by Regions
- 11.2.1 Global Dry Eye Drugs Forecast by Regions (2019-2024)
- 11.2.2 Global Dry Eye Drugs Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Dry Eye Drugs Forecast by Type
- 11.8 Global Dry Eye Drugs Forecast by Application
12 Key Players Analysis
- 12.1 Allergan
- 12.1.1 Company Details
- 12.1.2 Dry Eye Drugs Product Offered
- 12.1.3 Allergan Dry Eye Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Allergan News
- 12.2 Novartis AG
- 12.2.1 Company Details
- 12.2.2 Dry Eye Drugs Product Offered
- 12.2.3 Novartis AG Dry Eye Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Novartis AG News
- 12.3 Valeant Pharmaceuticals
- 12.3.1 Company Details
- 12.3.2 Dry Eye Drugs Product Offered
- 12.3.3 Valeant Pharmaceuticals Dry Eye Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Valeant Pharmaceuticals News
- 12.4 Santen Pharma
- 12.4.1 Company Details
- 12.4.2 Dry Eye Drugs Product Offered
- 12.4.3 Santen Pharma Dry Eye Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Santen Pharma News
- 12.5 Shire
- 12.5.1 Company Details
- 12.5.2 Dry Eye Drugs Product Offered
- 12.5.3 Shire Dry Eye Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Shire News
- 12.6 Johnson & Johnson
- 12.6.1 Company Details
- 12.6.2 Dry Eye Drugs Product Offered
- 12.6.3 Johnson & Johnson Dry Eye Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Johnson & Johnson News
- 12.7 United Laboratories
- 12.7.1 Company Details
- 12.7.2 Dry Eye Drugs Product Offered
- 12.7.3 United Laboratories Dry Eye Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 United Laboratories News
- 12.8 Senju Pharmaceutical
- 12.8.1 Company Details
- 12.8.2 Dry Eye Drugs Product Offered
- 12.8.3 Senju Pharmaceutical Dry Eye Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Senju Pharmaceutical News
- 12.9 Jianfeng Group
- 12.9.1 Company Details
- 12.9.2 Dry Eye Drugs Product Offered
- 12.9.3 Jianfeng Group Dry Eye Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Jianfeng Group News
- 12.10 Eusan GMBH
- 12.10.1 Company Details
- 12.10.2 Dry Eye Drugs Product Offered
- 12.10.3 Eusan GMBH Dry Eye Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Eusan GMBH News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Dry Eye Drugs . Industry analysis & Market Report on Dry Eye Drugs is a syndicated market report, published as Global Dry Eye Drugs Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Dry Eye Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
